Skip to content

CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2011-08-15

What CATALYST PHARMACEUTICALS, INC. reported in its quarterly report filed 2011-08-15 (fiscal Q2 2011): 25 published measures, 72 facts as tagged in accession 0001193125-11-223174.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-15
Fiscal period
fiscal Q2 2011
Accession
0001193125-11-223174 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CATALYST PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-305,610,089USD
At 2010-12-315,831,488USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-30656,136USD
At 2010-12-31313,709USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-304,953,953USD
At 2010-12-315,517,779USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-303,406,091USD
At 2010-12-315,475,158USD
At 2010-06-305,608,368USD
At 2009-12-317,779,277USD
At 2002-01-03100,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,394,151USD91
2011-01-01 to 2011-06-30-2,911,287USD181
2002-01-04 to 2011-06-30-34,622,842USD3465
2010-04-01 to 2010-06-30-1,328,541USD91
2010-01-01 to 2010-06-30-2,373,584USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-2,294,213USD181
2002-01-04 to 2011-06-30-28,743,760USD3465
2010-01-01 to 2010-06-30-2,170,909USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,800USD181
2002-01-04 to 2011-06-30101,006USD3465

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-302,228,634USD181
2002-01-04 to 2011-06-3034,152,545USD3465

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-2,003,488USD181
2002-01-04 to 2011-06-30-2,102,694USD3465

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-34,622,842USD
At 2010-12-31-31,711,555USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-3025,733USD
At 2010-12-3145,573USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-30118,827USD181
2002-01-04 to 2011-06-305,324,253USD3465
2010-01-01 to 2010-06-30168,135USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-1,397,463USD91
2011-01-01 to 2011-06-30-2,916,713USD181
2002-01-04 to 2011-06-30-36,095,072USD3465
2010-04-01 to 2010-06-30-1,333,132USD91
2010-01-01 to 2010-06-30-2,383,544USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-305,573,845USD
At 2010-12-315,775,404USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-30656,136USD
At 2010-12-31298,961USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-06-30478,011USD
At 2010-12-31105,933USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-301,397,463USD91
2011-01-01 to 2011-06-302,916,713USD181
2002-01-04 to 2011-06-3036,584,030USD3465
2010-04-01 to 2010-06-301,333,132USD91
2010-01-01 to 2010-06-302,383,544USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-30905,635USD91
2011-01-01 to 2011-06-301,809,588USD181
2002-01-04 to 2011-06-3024,069,331USD3465
2010-04-01 to 2010-06-30797,935USD91
2010-01-01 to 2010-06-301,237,522USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3021,654,680shares
At 2010-12-3119,394,737shares

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2011-06-30178,125USD
At 2010-12-31193,028USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-06-30166,066USD
At 2010-12-31166,221USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30491,828USD91
2011-01-01 to 2011-06-301,107,125USD181
2002-01-04 to 2011-06-3012,514,699USD3465
2010-04-01 to 2010-06-30535,197USD91
2010-01-01 to 2010-06-301,146,022USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-3027,468USD181
2002-01-04 to 2011-06-30138,622USD3465
2010-01-01 to 2010-06-3013,080USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-302,228,634USD181
2002-01-04 to 2011-06-3030,260,358USD3465

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-30372,078USD181
2002-01-04 to 2011-06-30478,011USD3465
2010-01-01 to 2010-06-302,334USD181

Inspect the source

Entity
CATALYST PHARMACEUTICALS, INC. / CIK 0001369568
Captured
2026-09-21T17:19:25.463Z
SEC response SHA-256
7cf76a511a9127dd31ed7d53955bbe348f790d8d7fd354d359e6674e7b2af9c9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001369568.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))